These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 26465118)

  • 1. NG2 Proteoglycan-Dependent Contributions of Pericytes and Macrophages to Brain Tumor Vascularization and Progression.
    Stallcup WB; You WK; Kucharova K; Cejudo-Martin P; Yotsumoto F
    Microcirculation; 2016 Feb; 23(2):122-33. PubMed ID: 26465118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NG2 proteoglycan-dependent recruitment of tumor macrophages promotes pericyte-endothelial cell interactions required for brain tumor vascularization.
    Yotsumoto F; You WK; Cejudo-Martin P; Kucharova K; Sakimura K; Stallcup WB
    Oncoimmunology; 2015 Apr; 4(4):e1001204. PubMed ID: 26137396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NG2 proteoglycan promotes tumor vascularization via integrin-dependent effects on pericyte function.
    You WK; Yotsumoto F; Sakimura K; Adams RH; Stallcup WB
    Angiogenesis; 2014 Jan; 17(1):61-76. PubMed ID: 23925489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan.
    Gibby K; You WK; Kadoya K; Helgadottir H; Young LJ; Ellies LG; Chang Y; Cardiff RD; Stallcup WB
    Breast Cancer Res; 2012 Apr; 14(2):R67. PubMed ID: 22531600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NG2 Proteoglycan in Pericyte Biology.
    Stallcup WB
    Adv Exp Med Biol; 2018; 1109():5-19. PubMed ID: 30523586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NG2-proteoglycan-dependent contributions of oligodendrocyte progenitors and myeloid cells to myelin damage and repair.
    Kucharova K; Stallcup WB
    J Neuroinflammation; 2015 Sep; 12():161. PubMed ID: 26338007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse.
    Huang FJ; You WK; Bonaldo P; Seyfried TN; Pasquale EB; Stallcup WB
    Dev Biol; 2010 Aug; 344(2):1035-46. PubMed ID: 20599895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours.
    Chekenya M; Enger PØ; Thorsen F; Tysnes BB; Al-Sarraj S; Read TA; Furmanek T; Mahesparan R; Levine JM; Butt AM; Pilkington GJ; Bjerkvig R
    Neuropathol Appl Neurobiol; 2002 Oct; 28(5):367-80. PubMed ID: 12366818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice.
    Girolamo F; Errede M; Longo G; Annese T; Alias C; Ferrara G; Morando S; Trojano M; Kerlero de Rosbo N; Uccelli A; Virgintino D
    PLoS One; 2019; 14(3):e0213508. PubMed ID: 30870435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting pericytes diminishes neovascularization in orthotopic uveal melanoma in nerve/glial antigen 2 proteoglycan knockout mouse.
    Ozerdem U
    Ophthalmic Res; 2006; 38(5):251-4. PubMed ID: 16888406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor.
    Brand C; Schliemann C; Ring J; Kessler T; Bäumer S; Angenendt L; Mantke V; Ross R; Hintelmann H; Spieker T; Wardelmann E; Mesters RM; Berdel WE; Schwöppe C
    Oncotarget; 2016 Feb; 7(6):6774-89. PubMed ID: 26735180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels.
    Iivanainen E; Lauttia S; Zhang N; Tvorogov D; Kulmala J; Grenman R; Salven P; Elenius K
    Microvasc Res; 2009 Dec; 78(3):278-85. PubMed ID: 19596357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NG2 Proteoglycan Enhances Brain Tumor Progression by Promoting Beta-1 Integrin Activation in both Cis and Trans Orientations.
    Stallcup WB
    Cancers (Basel); 2017 Mar; 9(4):. PubMed ID: 28362324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan.
    Ozerdem U; Stallcup WB
    Angiogenesis; 2004; 7(3):269-76. PubMed ID: 15609081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of pericytes diminishes neovascularization and lymphangiogenesis in prostate cancer.
    Ozerdem U
    Prostate; 2006 Feb; 66(3):294-304. PubMed ID: 16245280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progenitor/Stem Cell Markers in Brain Adjacent to Glioblastoma: GD3 Ganglioside and NG2 Proteoglycan Expression.
    Lama G; Mangiola A; Proietti G; Colabianchi A; Angelucci C; D' Alessio A; De Bonis P; Geloso MC; Lauriola L; Binda E; Biamonte F; Giuffrida MG; Vescovi A; Sica G
    J Neuropathol Exp Neurol; 2016 Feb; 75(2):134-47. PubMed ID: 26792897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma.
    Wang J; Svendsen A; Kmiecik J; Immervoll H; Skaftnesmo KO; Planagumà J; Reed RK; Bjerkvig R; Miletic H; Enger PØ; Rygh CB; Chekenya M
    PLoS One; 2011; 6(7):e23062. PubMed ID: 21829586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NG2 proteoglycan promotes angiogenesis-dependent tumor growth in CNS by sequestering angiostatin.
    Chekenya M; Hjelstuen M; Enger PØ; Thorsen F; Jacob AL; Probst B; Haraldseth O; Pilkington G; Butt A; Levine JM; Bjerkvig R
    FASEB J; 2002 Apr; 16(6):586-8. PubMed ID: 11919162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of interaction between NG2 proteoglycan and galectin-3.
    Wen Y; Makagiansar IT; Fukushi J; Liu FT; Fukuda MN; Stallcup WB
    J Cell Biochem; 2006 May; 98(1):115-27. PubMed ID: 16365873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type-2 pericytes participate in normal and tumoral angiogenesis.
    Birbrair A; Zhang T; Wang ZM; Messi ML; Olson JD; Mintz A; Delbono O
    Am J Physiol Cell Physiol; 2014 Jul; 307(1):C25-38. PubMed ID: 24788248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.